Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells.
Fraunhoffer NA, Moreno Vega AI, Abuelafia AM, Morvan M, Lebarbier E, Mary-Huard T, Zimmermann MT, Lomberk G, Urrutia R, Dusetti N, Blum Y, Nicolle R, Iovanna J.
Fraunhoffer NA, et al. Among authors: lebarbier e.
EBioMedicine. 2023 Jun;92:104602. doi: 10.1016/j.ebiom.2023.104602. Epub 2023 May 4.
EBioMedicine. 2023.
PMID: 37148583
Free PMC article.